A British Nobel-winning virologist has launched a programme to develop the world’s first hepatitis C vaccine after joining a university in Hong Kong, tapping the city’s research funding, access to Chinese strains of the virus and partnerships with mainland drug-makers.
Sir Michael Houghton, who won the 2020 Nobel Prize in Physiology or Medicine for the co-discovery of the hepatitis C virus, said he joined Baptist University after more than four decades in North America, as the United States and…
